Literature DB >> 11204554

Isoniazid- and rifampicin-induced oxidative hepatic injury--protection by N-acetylcysteine.

S Attri1, S V Rana, K Vaiphei, C P Sodhi, R Katyal, R C Goel, C K Nain, K Singh.   

Abstract

The role of N-acetylcysteine (NAC), a glutathione (GSH) precursor, was investigated in protection against isoniazid- (INH) and rifampicin- (RIF) induced oxidative hepatic injury in young Wistar rats. The hepatotoxic dose of INH and RIF was 50 mg kg(-1) day(-1) each and the hepatoprotective dose of NAC was 100 mg kg(-1) day(-1). All drugs were administered intraperitoneally (i.p.) in sterile water (4.0 ml kg(-1) day(-1)) over a period of 3 weeks. Status of oxidative/antioxidative profiles was the mechanistic approach to assess the hepatotoxicity and/or hepatoprotection. The oxidative injury in INH-RIF co-exposed animals was closely associated with significant decline of GSH and related thiols, as well as with compromised antioxidant enzyme system. The oxidative stress was further supported by increased lipid peroxidation observed in these animals. The co-administration of NAC prevented the induction of oxidative stress in INH-RIF co-exposed animals. The amelioration of oxidative stress by NAC was faithfully reflected as normal morphology in these animals, except the presence of mild degree of portal triaditis in one animal co-exposed to INH-RIF and NAC. In contrast, the animals co-exposed to INH-RIF alone showed histological lesions which ranged from intralobular inflammation to patchy necrosis. These results suggest that INH-RIF-induced oxidative injury can be prevented by supporting the cellular antioxidant defense mechanism by NAC.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11204554     DOI: 10.1191/096032700674230830

Source DB:  PubMed          Journal:  Hum Exp Toxicol        ISSN: 0960-3271            Impact factor:   2.903


  28 in total

1.  Liver and pancreatic injury induced by antituberculous therapy.

Authors:  M Markov; K Patel; A Raeesy; A Bant; D H Van Thiel; A Nadir
Journal:  Dig Dis Sci       Date:  2007-02-15       Impact factor: 3.199

2.  Pyrazinamide-induced hepatotoxicity and gender differences in rats as revealed by a 1H NMR based metabolomics approach.

Authors:  He Zhao; Zhi-Hong Si; Ming-Hui Li; Lei Jiang; Yong-Hong Fu; Yue-Xiao Xing; Wei Hong; Ling-Yu Ruan; Pu-Ming Li; Jun-Song Wang
Journal:  Toxicol Res (Camb)       Date:  2016-10-05       Impact factor: 3.524

3.  Diallyl trisulfide protects the liver against hepatotoxicity induced by isoniazid and rifampin in mice by reducing oxidative stress and activating Kupffer cells.

Authors:  Yilin Yang; Lulu Jiang; Shuo Wang; Tao Zeng; Keqin Xie
Journal:  Toxicol Res (Camb)       Date:  2016-04-01       Impact factor: 3.524

Review 4.  Hepatotoxicity Related to Anti-tuberculosis Drugs: Mechanisms and Management.

Authors:  Vidyasagar Ramappa; Guruprasad P Aithal
Journal:  J Clin Exp Hepatol       Date:  2012-12-20

5.  Effect of different oral doses of isoniazid-rifampicin in rats.

Authors:  Satya V Rana; Ravinder Pal; Kim Vaiphie; Kartar Singh
Journal:  Mol Cell Biochem       Date:  2006-04-01       Impact factor: 3.396

6.  Evaluation of hepatoprotective activity of Cissus quadrangularis stem extract against isoniazid-induced liver damage in rats.

Authors:  A H M Viswanatha Swamy; Rucha V Kulkarni; A H M Thippeswamy; B C Koti; Aparna Gore
Journal:  Indian J Pharmacol       Date:  2010-12       Impact factor: 1.200

7.  Rifampicin-isoniazid induced fatal fulminant hepatitis during treatment of latent tuberculosis: A case report and literature review.

Authors:  Fahmi Yousef Khan; Fatima Rasoul
Journal:  Indian J Crit Care Med       Date:  2010-04

8.  Protective effects of kaempferol on isoniazid- and rifampicin-induced hepatotoxicity.

Authors:  Tung-Yuan Shih; Ton-Ho Young; Herng-Sheng Lee; Chung-Bao Hsieh; Oliver Yoa-Pu Hu
Journal:  AAPS J       Date:  2013-04-17       Impact factor: 4.009

9.  Rifampicin exacerbates isoniazid-induced toxicity in human but not in rat hepatocytes in tissue-like cultures.

Authors:  C Shen; Q Meng; G Zhang; W Hu
Journal:  Br J Pharmacol       Date:  2007-12-10       Impact factor: 8.739

10.  Hepatoprotective Activity of Ficus carica Leaf Extract on Rifampicin-Induced Hepatic Damage in Rats.

Authors:  N Y Gond; S S Khadabadi
Journal:  Indian J Pharm Sci       Date:  2008 May-Jun       Impact factor: 0.975

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.